NOVELTY PHARMACEUTICAL / TECHNOLOGY

Dissolving Microneedles

We develop dissolving microneedle formats for targeted skincare and new delivery applications. Our work brings formulation, array design, and manufacturing together around the needs of each product.

THE PRINCIPLE

How dissolving microneedles work

Dissolving microneedles are tiny, preformed structures made from water-soluble materials. They are arranged in arrays for controlled contact with the skin.

With the right material, geometry, and application method, the needles can pass through the outer skin barrier. Moisture then hydrates and dissolves the soluble material, releasing ingredients held within it.

Needle length, insertion depth, and ingredient distribution are separate measurements. Each product needs testing to determine where its ingredients go and how they are released.

DISSOLVING MICRONEEDLES

How the microneedle array works

  1. The array01

    The array

  2. Skin contact02

    Skin contact

  3. Ingredient release03

    Ingredient release

  4. Dissolution04

    Dissolution

Principle illustration, not to scale. It does not establish product-specific delivery depth or clinical outcomes.

WATCH THE PROCESS

See how it works

Watch animation.

MATERIALS & FORMULATION

Materials that shape performance

Hyaluronic acid and sodium hyaluronate are key materials in our microcrystal products. The soluble matrix forms the needles and influences hydration, dissolution, and compatibility with other ingredients.

Formulation choices affect every step. Concentration and molecular properties influence flow and mold filling. Drying affects structural integrity, while contact with moisture affects dissolution.

A finished product also includes support and application components. Backings, adhesives, protective layers, hydrogel patches, serums, and handles must work with the array. Dissolving needles do not mean that every part of the product dissolves.

Structure-forming matrix

Consider formability, hydration and dissolution.

Payload and formulation

Examine compatibility per product.

Support and attachment

Distinguish needles from other components.

Companion components

Match the specific product format.

MICROSTRUCTURE DESIGN

Design & specifications

View production-ready molds, large-area forming, and the structures behind our arrays.

Custom geometries and specifications are available. The design tip diameter is 10–12 μm. Our current production mold sizes are listed below as needle length / spacing, in micrometers (μm).

225 / 600 μm300 / 450 μm300 / 600 μm420 / 450 μm600 / 600 μm600 / 800 μm800 / 1000 μm
DESIGN CASE 01

300 / 450 μm

Needle length 300 μm · Spacing 450 μm

Design length: 300 μm. Original SEM annotations are retained. SEM measurements describe the pictured sample; they do not establish nominal length or skin penetration depth.

Company-supplied photograph of an eight-inch microneedle matrix held by blue-gloved hands

Product photograph · Eight-inch microneedle matrix

Original product photograph supplied by Novelty.

Open original image ↗

Design values and SEM measurements are shown separately. Measurement orientation, sample condition, and tolerances have not yet been documented. No shrinkage rate or acceptance range is inferred.

DESIGN CASE 02

300 / 600 μm

Needle length 300 μm · Spacing 600 μm

Design length: 300 μm. Original SEM annotations are retained. SEM measurements describe the pictured sample; they do not establish nominal length or skin penetration depth.

Design values and SEM measurements are shown separately. Measurement orientation, sample condition, and tolerances have not yet been documented. No shrinkage rate or acceptance range is inferred.

DESIGN CASE 03

600 / 800 μm

Needle length 600 μm · Spacing 800 μm

Design parameters are updated; microscopy images retain their original measurements. The design needle length is 600 μm; H1 on the SEM image is an image-specific measurement, not nominal needle length or skin penetration depth.

Design dimensions and SEM measurements are retained separately; measurement orientation, sample condition and specification tolerances remain to be documented.

DESIGN CASE 04

800 / 1000 μm

Needle length 800 μm · Spacing 1000 μm

Design parameters are updated; microscopy images retain their original measurements. The design needle length is 800 μm; H1 on the SEM image is an image-specific measurement, not nominal needle length or skin penetration depth.

Design dimensions and SEM measurements are retained separately; measurement orientation, sample condition and specification tolerances remain to be documented.

DESIGN TO FINISHED ARRAY

From design to finished array

Follow each stage: needle design, array layout, master fabrication, PDMS molding, microneedle fabrication, and SEM inspection.

Seven-stage design and forming workflow; follow arrows from 01 to 07
Open the full-size process diagram.
CHARACTERIZATION & EVALUATION

Test the structure. Measure the performance.

Structure

Examine needle shape, dimensions, integrity, and mechanical response under defined conditions.

Dissolution

Measure hydration and dissolution using a specified medium, temperature, and time period.

Delivery and use

Assess insertion, ingredient distribution, local tolerance, and usability with methods suited to the product.

Stability and packaging

Track changes in appearance, structure, and material condition during storage.

Results depend on the sample and test conditions. We identify the method, conditions, and measured outcome so the data can be interpreted in context.

IN VIVO RAMAN STUDY

In vivo Raman study

See how Raman signals vary across skin layers from 30 minutes to 6 hours after application, comparing hydrolyzed sodium hyaluronate with its microneedle formulation.

Hydrolyzed sodium hyaluronate · Signal distribution across the skin barrier over time
Original signal patterns with newly drawn labels and layout. Select to enlarge.
Microneedle formulation · Signal distribution across the skin barrier over time
Original signal patterns with newly drawn labels and layout. Select to enlarge.

What the data show

The report describes the non-microneedle sample as concentrated mainly in the stratum corneum at 1, 2, and 4 hours, reaching the viable epidermis by 6 hours. With microneedles, signals were observed in the dermal region at 30 minutes and across all three layers at later time points.

How to read the figures

Colors retain the original heatmap scale and show relative Raman signals within each image. They help locate signals across skin layers. The images do not provide a shared absolute concentration calibration or measure needle insertion depth. The topical sample had a reported dermal value of 0.03% at 6 hours.

Reported relative penetration

Sample0.5 h1 h2 h4 h6 h
Hydrolyzed sodium hyaluronate0%0.15%2.08%4.74%6.12%
Microneedle formulation6.32%9.53%11.48%16.91%22.74%
View reported epidermal and dermal data
Sample / layer0.5 h1 h2 h4 h6 h
Topical · epidermis0%0.15%2.08%4.74%6.09%
Topical · dermis0%0%0%0%0.03%
Microneedles · epidermis4.97%8.46%8.76%13.53%19.81%
Microneedles · dermis1.35%1.07%2.72%3.38%2.93%

Study conditions: one participant; forearm; three 1 × 1 cm² areas, with five measurement points per area. Testing used a HORIBA LabRAM Odyssey at 22 ± 2°C and 50 ± 10% relative humidity. Results are specific to this participant, these samples, and these conditions. Relative penetration is not absolute concentration, systemic absorption, or clinical efficacy.

Source: WEIPU report SHA01-23080115-JC-01, September 13, 2023. Methods: pages 4–5; figures: pages 9–10; data: pages 10–11. These excerpts do not replace the complete report.

FORMATS & APPLICATIONS

One platform. Different product formats.

Targeted patches

Formats for the eye area, forehead, between the brows, smile lines, lips, and localized care.

Facial rollers

Dissolving microcrystal rollers with handles, designed for a distinct application routine.

Wellness

A separate product category made to company standards in China. Sleep patch information is available; glucosamine patch details will follow.

R&D partnerships

Medical devices, pharmaceutical delivery, and animal health each have their own development and testing requirements.

QUESTIONS & ANSWERS

Common questions

Are longer needles better?

Not necessarily. The application site, material, and method matter. Needle length does not equal insertion depth.

How is a microcrystal patch different?

It contains a preformed array of microscopic structures. Product benefits must be established through testing.

Does the entire patch dissolve?

Usually only the soluble needles or matrix dissolve. Follow the product instructions for removing the backing and other components.

Are dissolving and hydrogel-forming needles the same?

No. Dissolving needles dissolve; hydrogel-forming needles swell. A companion hydrogel patch is a separate component.

What can an SEM image show?

It shows surface structure and dimensions. It does not establish delivery performance or clinical efficacy.

DISCUSS YOUR APPLICATION

Let’s discuss your application

Tell us where and how the product will be used. We can then discuss materials, design, manufacturing, and testing.

Contact our technical team ↗